Coronavirus small

PatentSight On-Demand Webinar

Antiviral Patents - How prepared are we to combat novel viral diseases?

To watch the recording, please submit the form below:

Watch the recording

Presenters

Gene Quinn
Gene Quinn
President
IPWatchdog.com
William Mansfield Books Round
William Mansfield
Head of Consulting and Customer Success
LexisNexis PatentSight
Andrew Berks-1
Andrew Berks
Partner
Ostrolenk Faber LLP

The technology landscape of Antiviral drugs

With the novel coronavirus spreading both fear and illness across the world, it is a worthwhile exercise to look at the patent landscape of antiviral vaccines. By analyzing  both the quality and quantity of the patent portfolios of the world's leading manufacturers and researchers, it is possible to evaluate the companies and research institutes  that are at the forefront of finding vaccines and cures for potentially deadly viral diseases.

Watch our webinar to learn more about:

  • The entire technology field and key players in antiviral vaccine market
  • Review of selected companies who have technologies related to coronavirus
  • Portfolio landscaping of global pharma leaders in this technology field
  • How PatentSight metrics evaluate the portfolio strength